Solvonis Therapeutics CEO Anthony Tennyson to Speak at WTR Virtual Insights Conference in September 2026

Solvonis Therapeutics CEO Anthony Tennyson to Speak at WTR Virtual Insights Conference in September 2026 →

Solvonis Therapeutics plc (LSE: SVNS), a late clinical-stage biopharmaceutical firm focused on small-molecule therapies for central nervous system disorders, announced that CEO Anthony Tennyson will present at the Water Tower Research Virtu…